feed,title,long_url,short_url
BioRxiv,"Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, A Potential Oral Drug Candidate for COVID-19 Treatment",https://biorxiv.org/cgi/content/short/2022.02.07.478848v1?rss=1,https://bit.ly/3uyJUDn
BioRxiv,Machine learning-based approach KEVOLVE efficiently identifies SARS-CoV-2 variant-specific genomic signatures,https://biorxiv.org/cgi/content/short/2022.02.07.479343v1?rss=1,https://bit.ly/3LfLRKR
BioRxiv,Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques,https://biorxiv.org/cgi/content/short/2022.02.06.479285v1?rss=1,https://bit.ly/3oTdWhN
BioRxiv,A potent SARS-CoV-2 neutralizing antibody recognizing a conserved epitope with broad mutant variant and SARS-CoV activity,https://biorxiv.org/cgi/content/short/2022.02.06.479332v1?rss=1,https://bit.ly/35MBE8s
BioRxiv,An mRNA vaccine candidate for the SARS-CoV-2 Omicron variant,https://biorxiv.org/cgi/content/short/2022.02.07.479348v1?rss=1,https://bit.ly/3J5RqJS
